NeuroMetrix Cost Cutting and Product Introductions Not Enough to Appease Investors
NeuroMetrix continues to get hammered by investors who have left the company for dead. In May, NeuroMetrix laid off 15% of its work force. The […]
News
Cynosure Q2: Continued Growth and Profitability
Quarterly revenues at Cynosure, a developer of laser-based aesthetic systems, grew 30% year-over-year, from $30.1 million in Q2 2007 to $39.2 million in the most […]
Cepheid: Q2 Revenues Up 55 Percent, Loss Widens
On Thursday, Cepheid reported $42.1 million in quarterly revenues, a 55% jump from the $27.2 million reported in the same period last year. Growth has […]
AngioDynamics Reports Better Than Expected Quarterly Profit
Regular readers will know I’m bullish on AngioDynamics. Yesterday, the Queensbury NY-based company reported better than expected quarterly profit, buoyed by strong sales in its […]
[Video] New Developments at Chembio Diagnostics
Chembio Diagnostics develops, manufactures and markets rapid, point-of-care tests for the detection of HIV 1/ 2, Chagas and Sickle Cell disease as well as other […]
Tattoo Regret Could be a Boon for Device Manufacturers
I’ll never get a tattoo. Call me conservative, but the thought of having an ink-based design etched permanently into my skin is more than the […]
NxStage Releases New Patient Data; Remains Committed to Top Line Growth
NxStage Medical, a Lawrence, MA company that makes dialysis systems, has released new end-stage renal-disease (ESRD) patient data. The information was derived from a registry […]
Cynosure’s Smartlipo Gets CE Mark; U.S. Sales to Impact Second Quarter Results
For the morbidly obese (BMI > 40), liposuction is not really an option. But for a much broader set of women – those with fat […]
Q2 Earnings Report: ICU Medical
San Clemente, CA-based ICU Medical nearly doubled net income despite stagnating top line growth and a poor-performing critical care business. Second quarter revenue was $48.6 […]
One in Four Americans Obese
One in four Americans is now obese, says the CDC. While it’s less than welcome news, you can hardly say it’s surprising – we’ve been […]